This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is (are) precipitating factor(s) that can decrease the patient's ability to ... (Read 43 times)

lilldybug07

  • Hero Member
  • *****
  • Posts: 546
Which of the following is (are) precipitating factor(s) that can decrease the patient's ability to generate a negative intrapleural pressure?
 
  1. Supine position
  2. Large tidal volume on the mechanical ventilator
  3. Malnutrition
  4. Obesity
  a. 4
  b. 1, 3, 4
  c. 1, 2, 3
  d. 1, 2, 3, 4

Question 2

All of the following medications may be used to prevent pulmonary emboli EXCEPT:
 
  a. enoxaparin.
  b. dalteparin.
  c. tinzaparin.
  d. reteplase.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aidanmbrowne

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

B
A small tidal volume on the mechanical ventilator and all of the other listed options can decrease a patient's ability to generate a negative intrapleural pressure.

Answer to Question 2

D
Enoxaparin, dalteparin, and tinzaparin are all lowmolecular weight heparins that are anticoagulants used in the prevention of pulmonary emboli. Reteplase is a thrombolytic used in the treatment, not prevention, of pulmonary emboli.




lilldybug07

  • Member
  • Posts: 546
Reply 2 on: Jul 16, 2018
YES! Correct, THANKS for helping me on my review


kjohnson

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

The average adult has about 21 square feet of skin.

For a complete list of videos, visit our video library